StockNews.com Initiates Coverage on American Shared Hospital Services (NYSEAMERICAN:AMS)

Equities researchers at StockNews.com assumed coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the stock.

American Shared Hospital Services Stock Performance

Shares of AMS stock opened at $3.06 on Tuesday. American Shared Hospital Services has a twelve month low of $2.16 and a twelve month high of $3.25. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.90 and a current ratio of 1.90. The firm has a market cap of $19.37 million, a P/E ratio of 34.00 and a beta of 0.66.

American Shared Hospital Services (NYSEAMERICAN:AMS) last released its quarterly earnings results on Wednesday, March 27th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.04. The company had revenue of $5.70 million for the quarter, compared to analysts’ expectations of $5.19 million. American Shared Hospital Services had a return on equity of 4.58% and a net margin of 2.86%. On average, equities analysts anticipate that American Shared Hospital Services will post 0.32 EPS for the current year.

Institutional Trading of American Shared Hospital Services

A hedge fund recently bought a new stake in American Shared Hospital Services stock. Empowered Funds LLC purchased a new position in shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned about 0.17% of American Shared Hospital Services as of its most recent filing with the SEC. 23.16% of the stock is owned by institutional investors and hedge funds.

American Shared Hospital Services Company Profile

American Shared Hospital Services provides radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.